Abstract
Antisense 2′-methoxy-oligoribonucleotides targeted to aberrant splice sites in two thalassemic human ß-globin pre-mRNAs, IVS2-654 and IVS2-705, expressed in HeLa cells efficiently restore correct splicing with the use of Lipofectamine, Cellfectin and DMRIE-C, in effect reactivating a defective ß-globin gene.